Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Information (Details 1)

v2.4.0.6
Condensed Consolidating Financial Information (Details 1) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Nov. 30, 2010
Condensed Consolidating Statement of Operations        
Sales $ 789.0 $ 1,191.4 $ 2,270.1 $ 3,224.5
Less - excise taxes (88.3) (225.0) (243.9) (607.8)
Net sales 700.7 966.4 2,026.2 2,616.7
COST OF PRODUCT SOLD (417.8) (614.5) (1,209.3) (1,680.6)
Gross profit 282.9 351.9 816.9 936.1
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (121.8) (176.1) (398.2) (512.2)
RESTRUCTURING CHARGES (0.8) 1.2 (11.6) (17.4)
IMPAIRMENT OF INTANGIBLE ASSETS   (6.9)   (6.9)
Operating income (loss) 160.3 170.1 407.1 399.6
EQUITY IN EARNINGS OF EQUITY METHOD INVESTEES 53.3 71.4 179.5 192.3
INTEREST EXPENSE, net (46.3) (49.1) (133.1) (147.9)
Income before income taxes 167.3 192.4 453.5 444.0
PROVISION FOR INCOME TAXES (62.5) (53.1) (111.5) (164.3)
Net income 104.8 139.3 342.0 279.7
Parent Company [Member]
       
Condensed Consolidating Statement of Operations        
Sales 513.6 176.5 850.3 511.9
Less - excise taxes (59.0) (36.2) (120.4) (92.8)
Net sales 454.6 140.3 729.9 419.1
COST OF PRODUCT SOLD (374.7) (71.6) (516.9) (207.4)
Gross profit 79.9 68.7 213.0 211.7
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (73.0) (73.3) (209.2) (219.9)
RESTRUCTURING CHARGES 1.2 (0.5) (4.3) (0.5)
Operating income (loss) 8.1 (5.1) (0.5) (8.7)
EQUITY IN EARNINGS OF EQUITY METHOD INVESTEES 248.9 171.5 530.7 374.5
INTEREST EXPENSE, net (69.7) (49.3) (187.9) (156.3)
Income before income taxes 187.3 117.1 342.3 209.5
PROVISION FOR INCOME TAXES (82.5) 22.2 (0.3) 70.2
Net income 104.8 139.3 342.0 279.7
Subsidiary Guarantors [Member]
       
Condensed Consolidating Statement of Operations        
Sales 426.5 574.0 1,345.8 1,503.1
Less - excise taxes (12.5) (28.0) (75.1) (81.8)
Net sales 414.0 546.0 1,270.7 1,421.3
COST OF PRODUCT SOLD (279.2) (342.0) (809.1) (896.9)
Gross profit 134.8 204.0 461.6 524.4
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (32.7) (70.0) (153.2) (190.2)
RESTRUCTURING CHARGES (0.8) (0.3) (4.2) (2.1)
IMPAIRMENT OF INTANGIBLE ASSETS   (6.9)   (6.9)
Operating income (loss) 101.3 126.8 304.2 325.2
EQUITY IN EARNINGS OF EQUITY METHOD INVESTEES 54.5 70.1 181.2 186.9
INTEREST EXPENSE, net 21.8 (1.0) 50.0 5.8
Income before income taxes 177.6 195.9 535.4 517.9
PROVISION FOR INCOME TAXES 26.2 (76.4) (98.3) (204.8)
Net income 203.8 119.5 437.1 313.1
Subsidiary Nonguarantors [Member]
       
Condensed Consolidating Statement of Operations        
Sales 182.0 552.1 528.0 1,525.5
Less - excise taxes (16.8) (160.8) (48.4) (433.2)
Net sales 165.2 391.3 479.6 1,092.3
COST OF PRODUCT SOLD (96.3) (285.3) (287.4) (818.1)
Gross profit 68.9 106.0 192.2 274.2
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (16.1) (58.7) (86.3) (177.3)
RESTRUCTURING CHARGES (1.2) 2.0 (3.1) (14.8)
Operating income (loss) 51.6 49.3 102.8 82.1
EQUITY IN EARNINGS OF EQUITY METHOD INVESTEES 1.6 3.2 4.2 4.8
INTEREST EXPENSE, net 1.6 1.2 4.8 2.6
Income before income taxes 54.8 53.7 111.8 89.5
PROVISION FOR INCOME TAXES (6.3) 1.5 (13.0) (27.9)
Net income 48.5 55.2 98.8 61.6
Eliminations [Member]
       
Condensed Consolidating Statement of Operations        
Sales (333.1) (111.2) (454.0) (316.0)
Net sales (331.1) (111.2) (454.0) (316.0)
COST OF PRODUCT SOLD 332.4 84.4 404.1 241.8
Gross profit (0.7) (26.8) (49.9) (74.2)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES   25.9 50.5 75.2
Operating income (loss) (0.7) (0.9) 0.6 1.0
EQUITY IN EARNINGS OF EQUITY METHOD INVESTEES (251.7) (173.4) (536.6) (373.9)
Income before income taxes (252.4) (174.3) (536.0) (372.9)
PROVISION FOR INCOME TAXES 0.1 (0.4) 0.1 (1.8)
Net income $ (252.3) $ (174.7) $ (535.9) $ (374.7)